Pelthos Therapeutics Inc. (PTHS)
NYSEAMERICAN: PTHS · Real-Time Price · USD
27.00
+0.85 (3.25%)
May 19, 2026, 4:00 PM EDT - Market closed
Pelthos Therapeutics Analyst Ratings
Total Analysts
7
Consensus Rating
Strong Buy
Price Target
$54.83
Upside
+103.07%
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Oppenheimer | Oppenheimer | Buy Maintains $62 → $66 | Buy | Maintains | $62 → $66 | +144.44% | May 15, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Initiates $50 | Buy | Initiates | $50 | +85.19% | Apr 1, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $60 → $62 | Buy | Maintains | $60 → $62 | +129.63% | Mar 20, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $60 | Strong Buy | Reiterates | $60 | +122.22% | Mar 19, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $48 | Buy | Initiates | $48 | +77.78% | Feb 27, 2026 |
| Roth Capital | Roth Capital | Strong Buy Maintains $57 → $55 | Strong Buy | Maintains | $57 → $55 | +103.70% | Feb 26, 2026 |
| Oppenheimer | Oppenheimer | Buy Maintains $57 → $60 | Buy | Maintains | $57 → $60 | +122.22% | Jan 26, 2026 |
| Lake Street | Lake Street | Strong Buy Initiates $50 | Strong Buy | Initiates | $50 | +85.19% | Dec 3, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Initiates $60 | Strong Buy | Initiates | $60 | +122.22% | Dec 3, 2025 |
| Roth Capital | Roth Capital | Strong Buy Initiates $57 | Strong Buy | Initiates | $57 | +111.11% | Nov 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Reiterates $50 → $57 | Buy | Reiterates | $50 → $57 | +111.11% | Nov 14, 2025 |
| Oppenheimer | Oppenheimer | Buy Initiates $50 | Buy | Initiates | $50 | +85.19% | Sep 2, 2025 |